
On Thursday, October 14, 2010, the stars will come out for the third annual New York City Benefit for CURE Epilepsy. This year the organization will welcome NYC’s Mayor Michael R. Bloomberg while the event will be hosted by George Stephanopoulos (Good Morning America and ABC News) and Alexandra Wentworth (Actress & comedian).
Tickets are still available so don’t miss your chance to rub shoulders with NYC’s elite. Visit
CURE’s site to reserve your seat now.
Event Details
Thursday October 14, 2010
5:30 pm Sponsor Reception
6:00 pm General Reception (Grand Ballroom Foyer)
7:00 pm Seated Dinner (Grand Ballroom)
Reservations required * Tickets held at the door * Business attire
Event will be held at the The Roosevelt Hotel
Location: 45 East 45th Street
New York, New York
For valet parking, enter at 45th Street at Madison.
The site is wheelchair accessible.
Tickets:
$200 Under 30 Ticket
One Dinner Ticket
$400 Friend
One Dinner Ticket
For more information call (312) 255-1801 (312) 255-1801 or email newyorkbenefit@CUREepilepsy.org.
Jessica Keenan Smith is a patient advocate and epilepsy community leader with more than 15 years of experience. As Founder and CEO of Living Well With Epilepsy and Executive Director of ASENT she bridges the gap between the scientific and patient communities, with a particular focus on the needs of the epilepsies. Jessica Keenan Smith is Founder and CEO of Living Well With Epilepsy, an award winning online resource for people affected by epilepsy to share stories and access in-depth information on the disease. Since 2009, Living Well With Epilepsy (https://livingwellwithepilepsy.com) has been featured in Forbes, Wired, NBC, NPR and the cover story of Epilepsy Advocate Magazine and has partnered with companies such as UCB, Lundbeck, Sunovion, Eisai, and more. Ms. Smith is also the Executive Director of the American Society for Experimental Neurotherapeutics (ASENT) (https://asent.org), an organization that brings together leaders from industry, academia, government and advocacy who are engaged in bringing drugs and devices to market across all neurologic disease states. In this role she is responsible for leading a successful scientific journal and annual scientific conference with speakers from all over the world.
Leave a Reply